XML 36 R25.htm IDEA: XBRL DOCUMENT v3.24.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2023
Fair Value Measurements [Abstract]  
Schedule of Fair Value Measurements The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2023 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
Description  Level   December 31,
2023
 
Assets:        
Investments held in Trust Account – U.S. Treasury Securities Money Market Fund   1   $120,000,366 
Schedule of Equity Instruments The following table presents information about the Company’s equity instruments that are measured at fair value at June 16, 2023, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.
   Level   June 16,
2023
 
Equity:        
Representative shares   3   $2,239,466 
Fair Value of Public Rights for common stock subject to redemption allocation   3   $1,398,400 
Schedule of Assumptions were Used in Valuing the Representative Shares The following assumptions were used in valuing the representative shares:
   June 16,
2023
 
Risk-free rate   5.15%
Volatility   5.7%
Implied DLOM (Discount for Lack of Marketability)   1.4%
Restricted term (in years)   1.17 
Schedule of Valued Based on Market Comparables The rights were valued based on market comparables. The following criteria was utilized to select comparable Special Purpose Acquisition Companies who were pre-business combination and included rights as part of their units that were publicly trading with significant time remaining to complete their initial business combination:
Criteria  Low   High 
IPO Proceeds (in millions of dollars)   50    240 
Warrant Coverage   
    1.0 
Rights Coverage (per unit)   0.06    0.20 
Remaining Months to Complete   
    10